Review of article: Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year cardiovascular disease risk in medicated postmenopausal women with type 2 diabetes: A 1-year, double-blind, randomized, controlled trial by Peter J. Curtis, PhD, Mike Sampson, MD, John Potter, MD, Ketan Dhatariya, MD, Paul A. Kroon, PhD, Aedin Cassidy, PhD (Diabetes Care 2012;35:226–32)